These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 28849081)

  • 21. DPP (Dipeptidyl Peptidase)-4 Inhibitor Attenuates Ang II (Angiotensin II)-Induced Cardiac Hypertrophy via GLP (Glucagon-Like Peptide)-1-Dependent Suppression of Nox (Nicotinamide Adenine Dinucleotide Phosphate Oxidase) 4-HDAC (Histone Deacetylase) 4 Pathway.
    Okabe K; Matsushima S; Ikeda S; Ikeda M; Ishikita A; Tadokoro T; Enzan N; Yamamoto T; Sada M; Deguchi H; Shinohara K; Ide T; Tsutsui H
    Hypertension; 2020 Apr; 75(4):991-1001. PubMed ID: 32160098
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CaMKII and PKA-dependent phosphorylation co-regulate nuclear localization of HDAC4 in adult cardiomyocytes.
    Helmstadter KG; Ljubojevic-Holzer S; Wood BM; Taheri KD; Sedej S; Erickson JR; Bossuyt J; Bers DM
    Basic Res Cardiol; 2021 Feb; 116(1):11. PubMed ID: 33590335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased KCNE2 Expression Participates in the Development of Cardiac Hypertrophy by Regulation of Calcineurin-NFAT (Nuclear Factor of Activated T Cells) and Mitogen-Activated Protein Kinase Pathways.
    Liu W; Deng J; Ding W; Wang G; Shen Y; Zheng J; Zhang X; Luo Y; Lv C; Wang Y; Chen L; Yan D; Boudreau RL; Song LS; Liu J
    Circ Heart Fail; 2017 Jun; 10(6):. PubMed ID: 28611128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LIM and cysteine-rich domains 1 regulates cardiac hypertrophy by targeting calcineurin/nuclear factor of activated T cells signaling.
    Bian ZY; Huang H; Jiang H; Shen DF; Yan L; Zhu LH; Wang L; Cao F; Liu C; Tang QZ; Li H
    Hypertension; 2010 Feb; 55(2):257-63. PubMed ID: 20026769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeted inhibition of calcineurin prevents agonist-induced cardiomyocyte hypertrophy.
    Taigen T; De Windt LJ; Lim HW; Molkentin JD
    Proc Natl Acad Sci U S A; 2000 Feb; 97(3):1196-201. PubMed ID: 10655507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of intermittent calcium-activated potassium channel (SK4) attenuates Ang II-induced hypertrophy of human-induced stem cell-derived cardiomyocytes via targeting Ras-Raf-MEK1/2-ERK1/2 and CN-NFAT signaling pathways.
    Zhao H; Wang X; Tang Y; Zhao Q; Huang C
    Cell Biol Int; 2023 Feb; 47(2):480-491. PubMed ID: 36273427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tanshinone IIA protects against cardiac hypertrophy via inhibiting calcineurin/NFATc3 pathway.
    Tan X; Li J; Wang X; Chen N; Cai B; Wang G; Shan H; Dong D; Liu Y; Li X; Yang F; Li X; Zhang P; Li X; Yang B; Lu Y
    Int J Biol Sci; 2011 Apr; 7(3):383-9. PubMed ID: 21494433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An adenosine A1 agonist 2-chloro-N6 cyclopentyladenosine inhibits the angiotensin II-induced cardiomyocyte hypertrophy through the calcineurin pathway.
    Zhang X; Xia J; Qian D; Wang Y; Lin Y; Huang X; Tan J
    Cardiology; 2014; 129(3):153-62. PubMed ID: 25277512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tropisetron inhibits high glucose-induced calcineurin/NFAT hypertrophic pathway in H9c2 myocardial cells.
    Asadi F; Razmi A; Dehpour AR; Shafiei M
    J Pharm Pharmacol; 2016 Apr; 68(4):485-93. PubMed ID: 26945895
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Astragaloside IV protects against cardiac hypertrophy via inhibiting the Ca2+/CaN signaling pathway.
    Lu M; Wang H; Wang J; Zhang J; Yang J; Liang L; Maslov LN
    Planta Med; 2014 Jan; 80(1):63-9. PubMed ID: 24338553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Crosstalk between FGF23- and angiotensin II-mediated Ca
    Mhatre KN; Wakula P; Klein O; Bisping E; Völkl J; Pieske B; Heinzel FR
    Cell Mol Life Sci; 2018 Dec; 75(23):4403-4416. PubMed ID: 30062428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of calcineurin in angiotensin II-induced cardiomyocyte hypertrophy and cardiac fibroblast hyperplasia of rats.
    Fu M; Xu S; Zhang J; Pang Y; Liu N; Su J; Tang C
    Heart Vessels; 1999; 14(6):283-8. PubMed ID: 10901483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nifedipine inhibits cardiac hypertrophy and left ventricular dysfunction in response to pressure overload.
    Ago T; Yang Y; Zhai P; Sadoshima J
    J Cardiovasc Transl Res; 2010 Aug; 3(4):304-13. PubMed ID: 20559781
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Imatinib activates pathological hypertrophy by altering myocyte calcium regulation.
    Barr LA; Makarewich CA; Berretta RM; Gao H; Troupes CD; Woitek F; Recchia F; Kubo H; Force T; Houser SR
    Clin Transl Sci; 2014 Oct; 7(5):360-7. PubMed ID: 24931551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carabin protects against cardiac hypertrophy by blocking calcineurin, Ras, and Ca2+/calmodulin-dependent protein kinase II signaling.
    Bisserier M; Berthouze-Duquesnes M; Breckler M; Tortosa F; Fazal L; de Régibus A; Laurent AC; Varin A; Lucas A; Branchereau M; Marck P; Schickel JN; Deloménie C; Cazorla O; Soulas-Sprauel P; Crozatier B; Morel E; Heymes C; Lezoualc'h F
    Circulation; 2015 Jan; 131(4):390-400; discussion 400. PubMed ID: 25369805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leptin-induced cardiomyocyte hypertrophy reveals both calcium-dependent and calcium-independent/RhoA-dependent calcineurin activation and NFAT nuclear translocation.
    Rajapurohitam V; Izaddoustdar F; Martinez-Abundis E; Karmazyn M
    Cell Signal; 2012 Dec; 24(12):2283-90. PubMed ID: 22917533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiotensin-(1-7) prevents cardiomyocyte pathological remodeling through a nitric oxide/guanosine 3',5'-cyclic monophosphate-dependent pathway.
    Gomes ER; Lara AA; Almeida PW; Guimarães D; Resende RR; Campagnole-Santos MJ; Bader M; Santos RA; Guatimosim S
    Hypertension; 2010 Jan; 55(1):153-60. PubMed ID: 19996065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of myofibrillogenesis regulator-1 aggravates cardiac hypertrophy induced by angiotensin II in mice.
    Li HL; She ZG; Li TB; Wang AB; Yang Q; Wei YS; Wang YG; Liu DP
    Hypertension; 2007 Jun; 49(6):1399-408. PubMed ID: 17420335
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polydatin attenuates cardiac hypertrophy through modulation of cardiac Ca2+ handling and calcineurin-NFAT signaling pathway.
    Ding W; Dong M; Deng J; Yan D; Liu Y; Xu T; Liu J
    Am J Physiol Heart Circ Physiol; 2014 Sep; 307(5):H792-802. PubMed ID: 25015961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of transient receptor potential vanilloid 3 channel (TRPV3) aggravated pathological cardiac hypertrophy via calcineurin/NFATc3 pathway in rats.
    Zhang Q; Qi H; Cao Y; Shi P; Song C; Ba L; Chen Y; Gao J; Li S; Li B; Sun H
    J Cell Mol Med; 2018 Dec; 22(12):6055-6067. PubMed ID: 30299584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.